| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.25 | 1e-15 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.21 | 9e-12 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.21 | 1e-10 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-09 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-08 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.26 | 5e-08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-08 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-07 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-07 |